Keyphrases
Peptide YY3-36
100%
Peptide Modification
100%
Receptor Internalization
100%
Arrestin-3
50%
Lipidation
50%
PEGylation
33%
Endocytosis
33%
Y2 Receptor
33%
Modified Peptide
16%
Peptide Drugs
16%
Receptor Residence Time
16%
Pharmacokinetics
16%
Endogenous Ligand
16%
Signaling Bias
16%
Extended Half-life
16%
Extender
16%
Arrestin
16%
Food Intake
16%
Potential Therapeutics
16%
Obesity Treatment
16%
Receptor-mediated Endocytosis
16%
Neuropeptide Y2 Receptor
16%
Dissociation Rate
16%
Receptor Signaling
16%
Receptor Binding
16%
Temporal Model
16%
Pharmacodynamics
16%
Koff
16%
Biochemistry, Genetics and Molecular Biology
Internalization
100%
Arrestin
100%
Endocytosis
75%
PEGylation
50%
Dissociation Rate Constant
25%
Pharmacokinetic
25%
Retention Time
25%
Pharmacodynamics
25%
Neuropeptide
25%
Immunology and Microbiology
Peptides
100%
Internalization
100%
Retina S Antigen
57%
Endocytosis
42%
PEGylation
28%
Pharmacokinetic
14%
Retention Time
14%
Pharmacodynamics
14%
Neuropeptide
14%
Dissociation Rate Constant
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Peptide YY [3-36]
100%
Retina S Antigen
66%
PEGylation
33%
Pharmacokinetic
16%
Neuropeptide Y2 Receptor
16%
Pharmacodynamics
16%